An Evidence-Based Incentive System for Medicare's End-Stage Renal Disease Program

References

• Bradley E. H., Herrin J., Elbel B., McNamara R. L., Magid D. J., Nallamothu B. K., Wang Y. F., Normand S. L. T., Spertus J. A., Krumholz H. M. Hospital quality for acute myocardial infarction: Correlation among process measures and relationship with short-term mortality. J. Amer. Medical Assoc. (2006) 296(1):72–78Crossref, Google Scholar
• de Boor C., Hollig K., Riemenschneider S.Box Splines (1993) (Springer, New York) Crossref, Google Scholar
• End-Stage Renal Disease Quality Incentive Program (QIP) (2010) . Accessed December 15, 2010, https://www.cms.gov/ESRDQualityImproveInit/Google Scholar
• Federal Register HCFA medicare program; ESRD program; composite rates and methodology for determining the rates; final notice. Federal Register (1986) 51:29403–29419Google Scholar
• Federal Register Payment for renal dialysis services final rule. Federal Register (2004) 69:66319Google Scholar
• Federal Register Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2006; proposed rule. Federal Register (2005) 70:45793Google Scholar
• Federal Register End-stage renal disease quality incentive program; final rule. Federal Register (2011) 76:628–646Google Scholar
• Fuloria P. C., Zenios S. A. Outcomes-adjusted reimbursement in a health-care delivery system. Management Sci. (2001) 47(6):735–751Link, Google Scholar
• Gibbons R. Incentives between firms (and within). Management Sci. (2005) 51(1):2–17Link, Google Scholar
• Hastie T., Tibshirani R., Friedman J.The Elements of Statistical Learning. Data Mining, Inference, and Prediction (2009) (Springer, New York) Crossref, Google Scholar
• Jha A. K. Measuring hospital quality: What physicians do? How patients fare? Or both? J. Amer. Medical Assoc. (2006) 296(1):95–97Crossref, Google Scholar
• Lee D. K. K., Chertow G. M., Zenios S. A. Re-exploring differences among for-profit and non-profit dialysis providers. Health Services Res. (2010) 45(3):633–646Crossref, Google Scholar
• Medicare Improvements for Patients and Providers Act (MIPPA) (2008) . Accessed December 15, 2010, http://www.govtrack.us/congress/bill.xpd?bill=h110–6331Google Scholar
• Medicare Prescription Drug, Improvement, and Modernization Act (MMA) (2003) . Accessed December 15, 2010, http://www.cms.hhs.gov/medicarereform/MMAactFullText.pdfGoogle Scholar
• Thamer M., Zhang Y., Kaufman J., Cotter D., Dong F., Hernan M. A. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. J. Amer. Medical Assoc. (2007) 297(15):1667–1674Crossref, Google Scholar
• U.S. Government Accounting Office (GAO) Medicare dialysis facilities: Beneficiary access stable and problems in payment system being addressed. (2004) . Report to Congressional Committees (GAO-04-450), GAO, Washington, DCGoogle Scholar
• U.S. Renal Data System (USRDS) (2005) . http://www.usrds.org/Google Scholar
• Wolfe R. A., Hulbert-Shearson T. E., Ashby V. B., Mahadevan S., Port F. K. Improvements in dialysis patient mortality are associated with improvements in urea reduction ratio and hematocrit, 1999 to 2002. Amer. J. Kidney Diseases (2005) 45(1):127–135Crossref, Google Scholar